Advertisement

Reactions Weekly

, Volume 1746, Issue 1, pp 149–149 | Cite as

Nivolumab

Primary hypothyroidism secondary to thyroiditis: case report
Case report
  • 20 Downloads

Reference

  1. Ganavi YP, et al. Nivolumab, an immune check point inhibitor induced thyroid dysfunction. Indian Journal of Endocrinology and Metabolism 22 (Suppl. 1): S48, Nov 2018. Available from: URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247653/ [abstract] - India

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations